Baxter International | BAX - Des Atouts

Prix De L'Action
17.40
Variation Quotidienne
-0.61 -3.39%
Mensuellement
-16.10%
Annuel
-49.70%
Q1 Prévisions
16.87




Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
AngioDynamics USD 285.41M 6.14M 2025-02
Artivion USD 857.66M 19.27M 2025-09
AtriCure USD 654.18M 18.74M 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Fresenius EUR 42.46B 1.14B 2025-09
Globus Medical USD 5.3B 207.12M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
J&J USD 199.21B 6.39B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.35B 374M 2025-09
Merit Medical Systems USD 2.69B 54.92M 2025-12
Quest Diagnostics USD 16.23B 28M 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12